Almost two years after it was put on hold by the FDA, the type 2 diabetes drug dapagliflozin received a vote of confidence from the agency’s advisory panel.

Are clinical trial names prophetic? PREVAIL may provide the answer.

An advisory panel to the FDA voted in favor of approval of the Watchman Left Atrial Appendage Closure device as an alternative to warfarin for people with atrial fibrillation who are at risk of strokes.

Despite concerns that certain smoking cessation therapies may increase the risk of cardiovascular events, a study published online Dec. 9 in Circulation found no such association.

Using statins for primary prevention of cardiovascular disease is associated with a lower risk of death from any cause, serious vascular events and revascularizations when compared with a placebo, a Clinical Evidence Synopsis published online Dec. 11 in JAMA found.

Patients with obstructive sleep apnea and resistant hypertension who used continuous positive airway pressure had lower blood pressure over a 12-week period, according to a study published online Dec. 11 in JAMA.  

Although clinicians use digoxin less frequently as newer, safer agents start taking its place, toxicity has not decreased, which suggests the need for better management and monitoring of the drug, according to a study published online Dec. 3 in Circulation: Heart Failure. 

A study in PLOS One concludes that whole organic milk provides a greater cardio-protective punch than other milks because of its fatty acids, according to the New York Times.